Atlas Trials

A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine

Clinical trial NCT07753265 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07753265
Sponsor
Changchun BCHT Biotechnology Co.
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Herpse Zoster
Start date
2026-08-13
Primary completion
2026-09-20
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.